First-line psychotherapy tops medications for PTSD

  • Merz J & al.
  • JAMA Psychiatry
  • 12 Jun 2019

  • International Clinical Digest
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Takeaway

  • A new meta-analysis suggests that first-line treatment with psychotherapy is more effective than first-line pharmacological treatments for posttraumatic stress disorder (PTSD).

Why this matters

  • Different treatment guidelines offer competing recommendations on the use of pharmacological therapy as a first-line treatment for PTSD, with the American Psychological Association and the International Society for Traumatic Stress advocating their first-line use, whereas the National Health and Medical Research Council and the National Institute of Health and Care Excellence advise the use of pharmacological therapies for second-line or adjuvant therapy only.

Study design

  • Meta-analysis of 12 randomized clinical trials involving 922 participants with PTSD who received pharmacologic, psychotherapeutic, or combination treatment.
  • Primary outcome: PTSD symptom severity.
  • Funding: None disclosed.

Key results

  • At the longest available follow-up, psychotherapy showed significantly greater benefit vs pharmacologic treatments in network (standard mean difference [SMD], −0.83; 95% CI, −1.59 to −0.07) and pairwise (SMD, −0.63; 95% CI, −1.18 to −0.09; 3 RCTs) meta-analyses.
  • No difference was observed between psychotherapy and combination treatment.
  • Combination treatment was significantly more beneficial than pharmacological treatments alone in network (SMD, −0.96; 95% CI, −1.87 to −0.04), but not pairwise meta-analysis, which included 2 RCTs (SMD, 1.02; 95% CI, 2.77 to 0.72). 
  • All 3 options were similarly accepted by patients.

Limitations

  • Heterogeneity between studies.

Coauthored with Antara Ghosh, PhD

Please confirm your acceptance

To gain full access to GPnotebook please confirm:

By submitting here you confirm that you have accepted Terms of Use and Privacy Policy of GPnotebook.

Submit